Other PI3 Kinase Inhibitors Immunotherapy Tyrosine Kinase Inhibitors FGF CD Protein Inhibitors Immune Checkpoint Inhibitors Hormone Therapy Cyclin Dependent Kinase Inhibitors Serine-Threonine Kinase Inhibitors | Melanoma | Solid Tumor | Urothelial Cancer | Non Small Cell Lung Cancer | Glioma | Esophageal Cancer | Estrogen Receptor Positive Breast Cancer | Gastric Cancer | Squamous Cell Carcinoma of Head and Neck | Breast Cancer |
---|---|---|---|---|---|---|---|---|---|---|
erdafitinib | ||||||||||
futibatinib | ||||||||||
pemigatinib | ||||||||||
nintedanib | ||||||||||
ABSK091 + AZD2014 | ||||||||||
GDC-0032 | ||||||||||
eFT226 | ||||||||||
Immunotherapy | ||||||||||
PD1 inhibitor | ||||||||||
CTLA4 inhibitor | ||||||||||
PD-L1 inhibitor | ||||||||||
CPL304110 | ||||||||||
fulvestrant | ||||||||||
palbociclib |